CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This research focuses on understanding the immune system's role in breast cancer development and progression. By examining immune selection in mammary cells, it aims to identify new strategies for prevention and treatment of breast cancer.
Breast cancer is the leading cause of cancer-related death in women worldwide.
Despite intense research that has led to improved clinical outcomes, a significant number of patients treated with standard therapies suffer from high toxicity and remain unresponsive.
In parallel, Immune-Checkpoint Inhibitors (ICI) have transformed cancer treatment by unleashing patients' immune system to combat cancer cells through immunoediting, a natural evolutionary process of removal of antigenic tumor clones.…
INSTITUTE OF CANCER RESEARCH: THE ROYAL CANCER HOSPITAL LBG
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
United Kingdom, London
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
